This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Albany Molecular Files Allegra Patent Lawsuits

ALBANY, N.Y. (AP) ¿ Albany Molecular Research Inc. said Tuesday it filed patent infringement lawsuits against drug developers Dr. Reddy's Laboratories Ltd. and Sandoz Inc. over patents dealing with Sanofi-Aventis' antihistamines Allegra and Allegra D.

Albany Molecular earns royalties from sales of Allegra from Sanofi-Aventis, as well as from the authorized generic. It filed the lawsuits in U.S. District Court in New Jersey, citing plans by Dr. Reddy's and Sandoz to market generic versions of the drugs.

In November, Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals Inc. settled a patent lawsuit with Sanofi-Aventis' over the allergy drugs Allegra and Nasacort. That deal will allow for sales of certain generic doses of the drugs early. Financial details of that settlement were not disclosed.

Shares of Albany Molecular fell 3 cents to $8.08 in morning trading.
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AMRI $17.35 0.87%
SAN $6.05 2.90%
TEVA $59.64 0.68%
AAPL $110.46 0.88%
FB $93.09 0.67%


Chart of I:DJI
DOW 17,090.54 +39.79 0.23%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,812.1050 +1.3170 0.03%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs